Clinical Trial

Study of GeneXpert Mycobacterium Tuberculosis/ Rifampicin (MTB/RIF) Versus the Routine Methods for Detection of Mycobacterium Tuberculosis

Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated May 13, 2024 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
1. Compare the performance of GeneXpert method with the routine methods including smear microscopy and Lowenstein-Jensen (LJ) media culture to choose the best available test for the diagnosis of TB. 2. To assess the GeneXpert MTB/RIF assay performance in detection of Mycobacterium tuberculosis in smear-negative sputum samples.
Protocol Amendment History 1 change
critical Trial status changed: Not Yet Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT06409572
Lead Sponsor Sohag University
Conditions Tuberculosis
Enrollment 80 participants
Start Date 2024-06
Primary Completion 2026-06 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-05-13